SPY383.63+6.93 1.84%
DIA315.24+5.66 1.83%
IXIC12,920.15+196.68 1.55%

BRIEF-Lee's Pharmaceutical Says Fondaparinux Sodium Injection Got Approval For Drug Registration From China's NMPA

· 02/05/2021 09:34
BRIEF-Lee's Pharmaceutical Says Fondaparinux Sodium Injection Got Approval For Drug Registration From China's NMPA

- Lee's Pharmaceutical Holdings Ltd 0950.HK:

  • FONDAPARINUX SODIUM INJECTION OBTAINED APPROVAL FOR DRUG REGISTRATION FROM NMPA OF PRC

Source text for Eikon: ID:nHKS8DsYFr

Further company coverage: 0950.HK


((Reuters.Briefs@thomsonreuters.com;))